Biotechnology Portfolio Biotechnology Fund Quote
| FBIOX Fund | USD 18.95 0.39 2.02% |
PerformanceWeak
| Odds Of DistressLow
|
Biotechnology Portfolio is trading at 18.95 as of the 28th of March 2025; that is 2.02% down since the beginning of the trading day. The fund's open price was 19.34. Biotechnology Portfolio has about a 24 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 28th of December 2024 and ending today, the 28th of March 2025. Click here to learn more.
The fund invests primarily in common stocks. It normally invests at least 80 percent of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. More on Biotechnology Portfolio Biotechnology
Moving together with Biotechnology Mutual Fund
Biotechnology Mutual Fund Highlights
| Thematic Idea | Monster Funds (View all Themes) |
| Fund Concentration | Fidelity Investments Funds, Large Funds, Health Funds, Monster Funds, Health, Fidelity Investments, Large, Health (View all Sectors) |
| Update Date | 31st of March 2025 |
| Expense Ratio Date | 29th of April 2023 |
| Fiscal Year End | February |
Biotechnology Portfolio Biotechnology [FBIOX] is traded in USA and was established 28th of March 2025. Biotechnology Portfolio is listed under Fidelity Investments category by Fama And French industry classification. The fund is listed under Health category and is part of Fidelity Investments family. The entity is thematically classified as Monster Funds. This fund currently has accumulated 4.78 B in assets under management (AUM) with no minimum investment requirementsBiotechnology Portfolio is currently producing year-to-date (YTD) return of 3.17% with the current yeild of 0.01%, while the total return for the last 3 years was 7.54%.
Check Biotechnology Portfolio Probability Of Bankruptcy
Instrument Allocation
Sector Allocation
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Biotechnology Mutual Fund. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Biotechnology Mutual Fund, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Biotechnology Portfolio Biotechnology Mutual Fund, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.
Top Biotechnology Portfolio Biotechnology Mutual Fund Constituents
| BPMC | Blueprint Medicines Corp | Stock | Health Care | |
| BIIB | Biogen Inc | Stock | Health Care | |
| GILD | Gilead Sciences | Stock | Health Care | |
| REGN | Regeneron Pharmaceuticals | Stock | Health Care | |
| ARGX | argenx NV ADR | Stock | Health Care | |
| MRNA | Moderna | Stock | Health Care | |
| AMGN | Amgen Inc | Stock | Health Care | |
| TGTX | TG Therapeutics | Stock | Health Care |
Biotechnology Portfolio Risk Profiles
| Mean Deviation | 0.9883 | |||
| Semi Deviation | 1.2 | |||
| Standard Deviation | 1.2 | |||
| Variance | 1.45 |
Biotechnology Portfolio Against Markets
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Portfolio financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Portfolio security.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |